FLORetina – ICOOR Meeting & the 5th World ROP Congress 2025

Uniting Global Efforts to Prevent Childhood Blindness​

Retinopathy of Prematurity (ROP) remains a leading and increasingly significant cause of visual impairment and blindness in children — particularly in low- and middle-income countries. According to global estimates, in 2010 alone, more than 32,000 infants developed bilateral visual loss due to ROP, with the highest burden observed in East and Southeast Asia, and the Pacific region.​In response to this global challenge, four World ROP Congresses have been successfully held to date. These congresses have served as vital forums for ophthalmologists, neonatologists, nurses, and public health professionals — those on the front lines of neonatal and pediatric eye care — to come together, share experiences, and collaborate on solutions.​This year, we are proud to announce that the 5th World ROP Congress will take place in joint partnership with FLORetina-ICOOR 2025, one of the world’s premier meetings in the field of retinal science and innovation.

A Unique Collaborative Platform​​

Bringing together the ROP community within the broader framework of FLORetina-ICOOR creates a unique opportunity for cross-disciplinary dialogue and partnership. The Congress aims to:​

Share cutting-edge research and clinical innovations in the diagnosis, management, and prevention of ROP​
Highlight global trends and data, with a focus on emerging regions experiencing a rise in ROP-related blindness​
Foster collaboration between neonatology and ophthalmology professionals​
Promote practical solutions for ROP screening, treatment, and health system strengthening in resource-limited settings​
Build global networks and partnerships dedicated to preventing avoidable childhood blindness

When and Where​

The World ROP Congress will be held in Florence, Fortezza da Basso on 4 and 5 December 2025.

Hosted by

​​​The national reference network for Retinopathy of Prematurity in Italy - ROP Italia - is dedicated to coordinating care, education, and research across neonatal units and ophthalmic centers, and plays a leading role in shaping Italy’s strategy for early detection and treatment of ROP.​